Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New developments in mechanisms of prostate cancer progression
Nicholas Howard, Marco Clementino, Donghern Kim, et al.
Seminars in Cancer Biology (2018) Vol. 57, pp. 111-116
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Mechanosensitive ion channel Piezo1 promotes prostate cancer development through the activation of the Akt/mTOR pathway and acceleration of cell cycle
Han Yu, Chao Liu, Dongfang Zhang, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 114
AI-DRIVEN Novel Approach for Liver Cancer Screening and Prediction Using Cascaded Fully Convolutional Neural Network
Piyush Kumar Shukla, Mohammed Zakariah, Wesam Atef Hatamleh, et al.
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 45
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
Stefania Crucitta, Federico Cucchiara, Ron H.J. Mathijssen, et al.
Cancer Treatment Reviews (2022) Vol. 104, pp. 102340-102340
Closed Access | Times Cited: 40
Review—Nanotechnology-Assisted Electrochemical Immunosensors for Human Reproductive Cancer Diagnostics: Toward Laboratory to Clinics to Personalized Health Care
R Kokilavani, Hiranmoy Kotal, Ajeet Kaushik, et al.
Journal of The Electrochemical Society (2024) Vol. 171, Iss. 5, pp. 057516-057516
Closed Access | Times Cited: 6
Immunotherapy in treatment of metastatic prostate cancer: An approach to circumvent immunosuppressive tumor microenvironment
Belinda Sun
The Prostate (2021) Vol. 81, Iss. 15, pp. 1125-1134
Closed Access | Times Cited: 35
The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer
Jialin Meng, Yi Liu, Shi‐Yang Guan, et al.
Cancer Medicine (2019) Vol. 8, Iss. 11, pp. 5202-5213
Open Access | Times Cited: 41
HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer
Jianming Lü, Chuanfan Zhong, Junqi Luo, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 26, pp. 927-944
Open Access | Times Cited: 32
Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer
Zhuifeng Guo, Chang He, Fan Yang, et al.
Bioscience Reports (2019) Vol. 39, Iss. 9
Open Access | Times Cited: 33
Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases
Abdul Quaiyoom Khan, Fareed Ahmad, Syed Shadab Raza, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 208-226
Open Access | Times Cited: 32
Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel‐like factors in prostate cancer
Jialin Meng, Xiaofan Lu, Yujie Zhou, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 10, pp. 5797-5810
Open Access | Times Cited: 31
NOTCH signaling pathway and non-coding RNAs in cancer
Jing Guo, Ping Li, Xiaomin Liu, et al.
Pathology - Research and Practice (2019) Vol. 215, Iss. 11, pp. 152620-152620
Closed Access | Times Cited: 30
Molecular regulation of prostate cancer by Galectin-3 and estrogen receptor
Deborah Simão Souza, Carla Macheroni, Gustavo J.S. Pereira, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer
Wei Peng, Huan Feng, Linhao Pang, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-15
Open Access | Times Cited: 8
Role of long non-coding RNA NEAT1 in the prognosis of prostate cancer patients
Junchao Bai, Guangyi Huang
Medicine (2020) Vol. 99, Iss. 22, pp. e20204-e20204
Open Access | Times Cited: 21
Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer
Lei Gao, Jialin Meng, Yong Zhang, et al.
Genomics (2020) Vol. 112, Iss. 6, pp. 4980-4992
Open Access | Times Cited: 21
Mesenchymal stem cells desensitize castration-resistant prostate cancer to docetaxel chemotherapy via inducing TGF-β1-mediated cell autophagy
Yang Yu, Fuhan Yang, Wentao Zhang, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Retracted: Knockdown of lnc RNA MNX 1‐ AS 1 suppresses cell proliferation, migration, and invasion in prostate cancer
Zongwu Li, Fangfei Wang, Shi‐Bao Zhang
FEBS Open Bio (2019) Vol. 9, Iss. 5, pp. 851-858
Open Access | Times Cited: 21
The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer
Xinyu Geng, Chunyang Chen, Yuhua Huang, et al.
International Journal of Medical Sciences (2020) Vol. 17, Iss. 11, pp. 1550-1560
Open Access | Times Cited: 19
A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression
Belinda Sun, Lin Tang, Xiaoguang Sun, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1322-1322
Open Access | Times Cited: 16
MiR26a reverses enzalutamide resistance in a bone-tumor targeted system with an enhanced effect on bone metastatic CRPC
Yuanyuan Wang, Jiyuan Chen, Luyao Gong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Long Non-coding RNA HOTAIR: A Biomarker and Therapeutic Target in Urological Tumors
Abida Abida, Lina Eltaib, Bshayer Hmdan Alhazmi, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155549-155549
Closed Access | Times Cited: 2
Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
Giovanni Luca Beretta, Nadia Zaffaroni
Frontiers in Chemistry (2019) Vol. 7
Open Access | Times Cited: 19
Apalutamide in combination with autophagy inhibitors improves treatment effects in prostate cancer cells
Daniel Eberli, Benedikt Kranzbühler, Ashkan Mortezavi, et al.
Urologic Oncology Seminars and Original Investigations (2020) Vol. 38, Iss. 8, pp. 683.e19-683.e26
Open Access | Times Cited: 16
Signal Crosstalk and the Role of Estrogen Receptor beta (ERβ) in Prostate Cancer
Jialin Li, Quanliang Liu, Chengming Jiang
Medical Science Monitor (2022) Vol. 28
Open Access | Times Cited: 11
HOTAIR in solid tumors: Emerging mechanisms and clinical strategies
Xiangchen An, Yili Liu
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113594-113594
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top